XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Cash Flows (Unaudited)
$ in Thousands, € in Millions
6 Months Ended
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Cash flows from operating activities:    
Net income $ 13,787 $ 8,878
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 6,333 4,172
Gain on disposal of property, plant & equipment (6,209) (21)
Share-based compensation 1,473 1,121
Interest expense on finance leases 3 1
Deferred income taxes (383) 383
Change in fair value of contingent consideration 6,002 0
Changes in operating assets and liabilities:    
Receivables, net (16,363) (4,794)
Inventories (15,212) (2,518)
Prepaid expenses and other current assets (1,320) (397)
Refundable income taxes (1,103) (870)
Other assets (3,004) (168)
Accounts payable 11,832 4,032
Accrued expenses 4,594 248
Deferred revenue 1,365 16
Non-qualified deferred compensation plan and other liabilities (1,830) (196)
Net cash (used in) provided by operating activities (35) 9,887
Cash flows from investing activities:    
Additions to property, plant, and equipment (8,502) (3,282)
Proceeds from sale of fixed assets 12 21
Net cash used in investing activities (29,143) (3,261)
Cash flows from financing activities:    
Proceeds from advances on revolving line of credit 34,000 0
Payments on revolving line of credit (7,000) 0
Principal payments of long-term debt (2,000) 0
Principal payments on finance lease obligations (32) (9)
Proceeds from exercise of stock options 21 162
Payment of statutory withholdings for restricted stock units vested (1,302) (740)
Net cash provided by (used in) financing activities 23,687 (587)
Effect of foreign currency exchange rates on cash and cash equivalents (50) 0
Net (decrease) increase in cash and cash equivalents (5,541) 6,039
Cash and cash equivalents at beginning of period 11,117 24,234
Cash and cash equivalents at end of period 5,576 30,273
Advant Medical [Member]    
Cash flows from investing activities:    
Acquisition, net of cash acquired (20,768) 0
DAS Medical [Member]    
Cash flows from investing activities:    
Acquisition, net of cash acquired $ 115 $ 0